
RGRX
Healthcare · Biotechnology · $1,646 market cap
$0.00110.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2017
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 10, 2023 | Time not confirmed | — | 0.00 | — |
| Aug 4, 2023 | Time not confirmed | — | 0.00 | — |
| Apr 11, 2023 | Time not confirmed | — | -0.53 | — |
| Mar 29, 2023 | Time not confirmed | — | -0.00 | — |
| Nov 14, 2022 | Time not confirmed | — | -0.00 | — |
| Aug 5, 2022 | Time not confirmed | — | -0.00 | — |
| May 17, 2022 | Time not confirmed | — | 0.01 | — |
| Mar 30, 2022 | Time not confirmed | — | 0.01 | — |
| Nov 12, 2021 | Time not confirmed | — | 0.01 | — |
| Aug 6, 2021 | Time not confirmed | — | 0.01 | — |
| May 18, 2021 | Time not confirmed | — | 0.01 | — |
| Mar 31, 2021 | Time not confirmed | — | -0.00 | — |
| Nov 13, 2020 | Time not confirmed | — | -0.00 | — |
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, develops pharmaceuticals from Thymosin beta 4 (Tß4) for tissue protection, repair, and regeneration. The company is developing RGN-259, a sterile and preservative-free eye drop that has completed Phase 3 clinical trial for the treatment of dry eye syndrome and neurotrophic keratitis. It has strategic partnerships with Lee's Pharmaceutical Group for the…
| Time not confirmed |
| — |
| -0.00 |
| — |
| May 12, 2020 | Time not confirmed | — | 0.01 | — |
| Mar 25, 2020 | Time not confirmed | — | 0.01 | — |
| Nov 15, 2019 | Time not confirmed | — | 0.01 | — |
| Aug 2, 2019 | Time not confirmed | — | 0.01 | — |
| May 14, 2019 | Time not confirmed | — | 0.01 | — |
| Mar 27, 2019 | Time not confirmed | — | 0.01 | — |
| Nov 9, 2018 | Time not confirmed | — | 0.01 | — |
| Aug 3, 2018 | Time not confirmed | — | -0.00 | — |
| May 15, 2018 | Time not confirmed | — | -0.01 | — |
| Mar 29, 2018 | After the close | — | 0.01 | — |